# St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)

> **NCT00118833** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 56 (estimated)

## Conditions studied

- Anxiety Disorders
- Mental Health

## Interventions

- **DRUG:** Hypericum perforatum (St. John's wort)

## Key facts

- **NCT ID:** NCT00118833
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118833, "St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00118833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*